MedTrace Logo

Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

NCT01226966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3152

Last updated 2017-02-13

No results posted yet for this study

Summary

This observational study is conducted in Europe. The aim of this non-interventional (observational) study is to evaluate the efficacy of liraglutide (Victoza®) and to assess the conditions of use of Victoza® in daily medical practice in France.

Conditions

Interventions

DRUG

liraglutide

Prescription is done at the discretion of the prescribing physician as part of normal clinical routine.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452), Medical Advisor · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • France

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01226966 on ClinicalTrials.gov